This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nolan, M. E. Articles by Muthuswamy, S. K. Search for Related Content PubMed PubMed Citation Articles by Nolan, M. E. Articles by Muthuswamy, S. K.

The Polarity Protein Par6 Induces Cell Proliferation and Is Overexpressed in Breast Cancer

¹ Graduate Program in Genetics, Stony Brook University, Stony Brook, New York; ² Watson School of Biological Sciences, ³ Cold Spring Harbor Laboratory, Cold Spring Harbor, New York; and ⁴ Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri

Requests for reprints: Senthil K. Muthuswamy, One Bungtown Road, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724. Phone: 516-367-6975; Fax: 516-367-8461; E-mail: muthuswa{at}cshl.edu.

Key Words: breast cancer • Par6 • polarity

The polarity protein complex Par6/atypical protein kinase (aPKC)/Cdc42 regulates polarization processes during epithelial morphogenesis, astrocyte migration, and axon specification. We, as well as others, have shown that this complex is also required for disruption of apical-basal polarity during the oncogene ErbB2-induced transformation and transforming growth factor β–induced epithelial-mesenchymal transition of mammary epithelial cells. Here, we report that expression of Par6 by itself in mammary epithelial cells induces epidermal growth factor–independent cell proliferation and development of hyperplastic three-dimensional acini without affecting apical-basal polarity. This is dependent on the ability of Par6 to interact with aPKC and Cdc42, but not Lgl and Par3, and its ability to promote sustained activation of MEK/ERK signaling. Down-regulation of Cdc42 or aPKC expression suppresses the ability of Par6 to induce proliferation, demonstrating that Par6 promotes cell proliferation by interacting with aPKC and Cdc42. We also show that Par6 is overexpressed in breast cancer–derived cell lines and in both precancerous breast lesions and advanced primary human breast cancers, suggesting that Par6 overexpression regulates tumor initiation and progression. Thus, in addition to regulating cell polarization processes, Par6 is an inducer of cell proliferation in breast epithelial cells. [Cancer Res 2008;68(20):8201–9]

This article has been cited by other articles:

				A. M. Viloria-Petit, L. David, J. Y. Jia, T. Erdemir, A. L. Bane, D. Pinnaduwage, L. Roncari, M. Narimatsu, R. Bose, J. Moffat, et al. A role for the TGF{beta}-Par6 polarity pathway in breast cancer progression PNAS, August 18, 2009; 106(33): 14028 - 14033. [Abstract] [Full Text] [PDF]